Free tool
FAERS Monitor: Kesimpta
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming BLA 125326 or its brand name (Kesimpta, Ofatumumab). Reports on generic versions are filed under their own applications.
Reports
33,639
Serious
14,965
44% of reports
Hospitalization
4,712
Death reported
779
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- fatigue5,591
- headache4,670
- pyrexia3,632
- pain3,599
- chills3,506
- influenza like illness2,934
- nausea1,832
- multiple sclerosis relapse1,741
- covid-191,523
- asthenia1,520
- multiple sclerosis1,516
- gait disturbance1,441
- hypoaesthesia1,411
- malaise1,391
- feeling abnormal1,368
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2008 | 2 |
| 2009 | 10 |
| 2010 | 102 |
| 2011 | 151 |
| 2012 | 235 |
| 2013 | 285 |
| 2014 | 275 |
| 2015 | 328 |
| 2016 | 232 |
| 2017 | 155 |
| 2018 | 162 |
| 2019 | 109 |
| 2020 | 680 |
| 2021 | 4,664 |
| 2022 | 7,299 |
| 2023 | 8,730 |
| 2024 | 4,695 |
| 2025 | 3,618 |
| 2026 | 1,907 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,020,520 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| influenza like illnessSignal | 2,934 | 23.1 | 22.3 | 59,971 |
| multiple sclerosisSignal | 1,516 | 20.4 | 19.4 | 27,184 |
| chillsSignal | 3,506 | 19.2 | 18.6 | 59,139 |
| multiple sclerosis relapseSignal | 1,741 | 16.3 | 15.5 | 24,383 |
| pyrexiaSignal | 3,632 | 6.6 | 6.4 | 17,435 |
| hypoaesthesiaSignal | 1,411 | 5.9 | 5.6 | 5,779 |
| covid-19Signal | 1,523 | 5.5 | 5.2 | 5,552 |
| gait disturbanceSignal | 1,441 | 4.7 | 4.5 | 4,249 |
| headacheSignal | 4,670 | 4.7 | 4.6 | 13,843 |
| fatigueSignal | 5,591 | 4.5 | 4.4 | 15,772 |
| painSignal | 3,599 | 3.7 | 3.6 | 7,187 |
| feeling abnormalSignal | 1,368 | 3.6 | 3.4 | 2,561 |
| astheniaSignal | 1,520 | 2.5 | 2.4 | 1,430 |
| malaise | 1,391 | 2.0 | 1.9 | 692 |
| nausea | 1,832 | 1.4 | 1.4 | 263 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.